AnPac Bio-Medical Science Co., Ltd. (ANPC) |
|
4.3 -0.14 (-3.15%)
|
05-19 15:59 |
|
Open: |
4.57 |
Pre. Close: |
4.44 |
|
High:
|
4.63 |
Low:
|
4.25 |
|
Volume:
|
35,704 |
Market Cap:
|
27(M) |
|
|
|
Technical analysis |
as of: 2023-06-09 1:13:18 PM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 8.4 One year: 10.71 |
| Support: |
Support1: 4 Support2: 3.32 |
| Resistance: |
Resistance1: 7.19 Resistance2: 9.17 |
| Pivot: |
4.67  |
| Moving Average: |
MA(5): 4.4 MA(20): 4.88
MA(100): 6.71 MA(250): 5.41 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 17.4 %D(3): 14.4 |
| RSI: |
RSI(14): 44.3 |
| 52-week: |
High: 11.98 Low: 2.59 |
| Average Vol(K): |
3-Month: 23 (K) 10-Days: 22 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ANPC ] has closed above bottom band by 43.2%. Bollinger Bands are 61.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.45 - 4.48 |
4.48 - 4.51 |
|
Low:
|
4.06 - 4.1 |
4.1 - 4.13 |
|
Close:
|
4.17 - 4.23 |
4.23 - 4.28 |
|
Company Description |
|
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China. |
Headline News |
Fri, 19 May 2023
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' - Yahoo Finance
Fri, 31 Mar 2023
AnPac Bio-Medical Science Announces Pricing of $3.0 Million ... - GlobeNewswire
Wed, 15 Feb 2023
AnPac Bio-Medical Science Acquires GISN - citybiz
Thu, 09 Feb 2023
AnPac Bio to acquire Fresh2 Ecommerce for $2.1M - Seeking Alpha
Wed, 25 Jan 2023
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements - Yahoo Finance
Mon, 05 Dec 2022
AnPac Announces Strategic Initiative to Establish A Wholly-Owned ... - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
6 (M) |
| Shares Float |
6 (M) |
|
% Held by Insiders
|
2.1 (%) |
|
% Held by Institutions
|
0.1 (%) |
|
Shares Short
|
44 (K) |
|
Shares Short P.Month
|
28 (K) |
Stock Financials |
|
EPS
|
-11.45 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
10.63 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-871.2 |
|
Return on Assets (ttm)
|
-52.7 |
|
Return on Equity (ttm)
|
-243.2 |
|
Qtrly Rev. Growth
|
-70 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
1.7 |
|
EBITDA (p.s.)
|
-14.04 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.41 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.43 |
|
Price to Sales
|
2.69 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
